10. Parenchymal transection methods: pair‐wise comparisonsa,b.
| Adverse events (proportion) | ||||
| Cavitron ultrasonic surgical aspirator | Hydrojet | Radiofrequency dissecting sealer | Sharp transection method | |
| Clamp‐crush method | OR 2.15; 95% CrI 0.11 to 108.74 | OR 0.57; 95% CrI 0.00 to 732.89 | OR 1.20; 95% CrI 0.05 to 33.05 | OR 1.11; 95% CrI 0.00 to 331.29 |
| Cavitron ultrasonic surgical aspirator | — | OR 0.27; 95% CrI 0.00 to 501.34 | OR 0.56; 95% CrI 0.01 to 62.38 | OR 0.52; 95% CrI 0.00 to 398.54 |
| Hydrojet | — | — | OR 2.12; 95% CrI 0.00 to 3638.36 | OR 1.94; 95% CrI 0.00 to 12959.09 |
| Radiofrequency dissecting sealer | — | — | — | OR 0.92; 95% CrI 0.00 to 638.06 |
| Sharp transection method | — | — | — | ‐ |
| Adverse events (number) | ||||
| Cavitron ultrasonic surgical aspirator | Hydrojet | Radiofrequency dissecting sealer | Sharp transection method | |
| Clamp‐crush method | rate ratio 1.60; 95% CrI 0.92 to 2.79 | rate ratio 1.40; 95% CrI 0.49 to 3.63 | rate ratio 1.84; 95% CrI 1.13 to 3.06 | rate ratio 1.13; 95% CrI 0.57 to 2.24 |
| Cavitron ultrasonic surgical aspirator | — | rate ratio 0.88; 95% CrI 0.28 to 2.75 | rate ratio 1.15; 95% CrI 0.54 to 2.42 | rate ratio 0.71; 95% CrI 0.29 to 1.71 |
| Hydrojet | — | — | rate ratio 1.31; 95% CrI 0.43 to 4.01 | rate ratio 0.81; 95% CrI 0.24 to 2.71 |
| Radiofrequency dissecting sealer | — | — | — | rate ratio 0.62; 95% CrI 0.26 to 1.44 |
| Sharp transection method | — | — | — | — |
| Blood transfusion (proportion) | ||||
| Cavitron ultrasonic surgical aspirator | Hydrojet | Radiofrequency dissecting sealer | Sharp transection method | |
| Clamp‐crush method | OR 1.48; 95% CrI 0.54 to 4.13 | OR 1.73; 95% CrI 0.47 to 6.25 | OR 1.09; 95% CrI 0.61 to 1.97 | OR 0.80; 95% CrI 0.31 to 2.03 |
| Cavitron ultrasonic surgical aspirator | — | OR 1.17; 95% CrI 0.23 to 6.05 | OR 0.74; 95% CrI 0.23 to 2.39 | OR 0.54; 95% CrI 0.14 to 2.15 |
| Hydrojet | — | — | OR 0.63; 95% CrI 0.15 to 2.61 | OR 0.46; 95% CrI 0.09 to 2.27 |
| Radiofrequency dissecting sealer | — | — | — | OR 0.73; 95% CrI 0.24 to 2.21 |
aThe table provides the effect estimate of each pair‐wise comparison. To identify the effect estimate of a comparison (e.g. A versus B), look at the cell that occupies the column corresponding to treatment A and the row corresponding to treatment B. This gives the information directly. If that cell is empty (indicated by a '—', you have to look at column corresponding to treatment B and row corresponding to treatment A. You will have to take the inverse of this number (i.e. 1/number) to get the treatment effect. bTreatment effects with evidence of difference are shown by italics (not applicable).